FDC Ltd. — Investor Relations & Filings
FDC Ltd. specializes in the manufacture and marketing of active ingredients and finished dosage forms. The company maintains a diverse portfolio across therapeutic segments, including anti-infectives, gastrointestinals, ophthalmics, and vitamins. It is widely recognized for its leadership in the oral rehydration salts (ORS) market with its flagship brand, Electral. Other notable products include Zifi, a broad-spectrum antibiotic, and Enerzal, a balanced energy drink. The organization operates multiple manufacturing facilities certified by global regulatory bodies and serves a broad range of markets. The company focuses on research and development to enhance its formulation capabilities and expand its footprint through strategic exports and partnerships.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Shareholders meeting | 2026-05-09 | English | |
| Corrigendum to Postal Ballot Notice dated April 21, 2026 | 2026-05-09 | English | |
| Disclosure under SEBI Takeover Regulations | 2026-05-07 | English | |
| Updates | 2026-04-24 | English | |
| Copy of Newspaper Publication | 2026-04-24 | English | |
| Shareholders meeting | 2026-04-22 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 44643950 | Shareholders meeting | 2026-05-09 | English | ||
| 44722756 | Corrigendum to Postal Ballot Notice dated April 21, 2026 | 2026-05-09 | English | ||
| 42492038 | Disclosure under SEBI Takeover Regulations | 2026-05-07 | English | ||
| 36126957 | Updates | 2026-04-24 | English | ||
| 36126965 | Copy of Newspaper Publication | 2026-04-24 | English | ||
| 42178664 | Shareholders meeting | 2026-04-22 | English | ||
| 42190539 | General Updates | 2026-04-21 | English | ||
| 42208175 | Certificate under SEBI (Depositories and Participants) Regulations, 2018 | 2026-04-10 | English | ||
| 42165679 | Trading Window | 2026-03-26 | English | ||
| 42215546 | Updates | 2026-03-20 | English | ||
| 42173994 | Change in Director(s) | 2026-03-18 | English | ||
| 42162408 | Disclosure under SEBI Takeover Regulations | 2026-02-19 | English | ||
| 42162551 | Disclosure under SEBI Takeover Regulations | 2026-02-19 | English | ||
| 42189419 | General Updates | 2026-02-17 | English | ||
| 42226692 | General Updates | 2026-02-10 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
CStone Pharmaceuticals
Innovation-driven biopharma focused on R&D and commercializ…
|
2616 | KY | Manufacturing |
|
CTC BIO, INC.
Develops and manufactures human and animal health products …
|
060590 | KR | Manufacturing |
|
Cue Biopharma, Inc.
Develops biologics to selectively modulate the immune syste…
|
CUE | US | Manufacturing |
|
Cullinan Therapeutics, Inc.
A clinical-stage biopharmaceutical company developing thera…
|
CGEM | US | Manufacturing |
|
CUMBERLAND PHARMACEUTICALS INC
Acquires, develops, and commercializes branded drugs for ho…
|
CPIX | US | Manufacturing |
|
Cuorips Inc.
Develops iPS cell-derived therapies and provides cell proce…
|
4894 | JP | Manufacturing |
|
Cuprina Holdings (Cayman) LTD
Biomedical firm developing wound care biotherapy and cosmec…
|
CUPR | US | Manufacturing |
|
Curaleaf
Cultivates, processes, and distributes medical and wellness…
|
CURA | CA | Manufacturing |
|
Curanex Pharmaceuticals Inc
Develops botanical drugs for inflammatory diseases like ulc…
|
CURX | US | Manufacturing |
|
Curasight A/S
A clinical-stage biotech developing a theranostic platform …
|
CURAS | DK | Manufacturing |
FDC Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/60812/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=60812 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=60812 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=60812 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 60812}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for FDC Ltd. (id: 60812)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.